Volver a Agenda
[V1-S6] What Information and Communication Do Patients Want in Clinical Trials? How We Can Provide Them? (Part 2)
Session Chair(s)
Yasuhiro Fujiwara, MD, PhD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshikata Furuya, MSc
Manager, General Affairs Division
Sankeien Hoshoukai Foundation, Japan
In order to engage patients as a partner in drug development and promote their involvement, it is important to understand patients’ needs in information and communication in clinical trials then provide them to patients. Disclosure of clinical trial information and provision of lay summaries of clinical trial results are beginning to be carried out in Japan. This session aims to understand what information and communication patients are seeking before, during and after clinical trials, and discuss how we should provide them to patients based on the regulations and case studies in Japan and global. In part 2 session, status in EU on patient communication will be stared and all speakers of part 1 and 2 sessions will have a panel discussion.
Speaker(s)
Efforts and Status in EU on Patient Communication and Information Sharing in Clinical Trials
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Industry’s Efforts on Patient Communication and Information Sharing in Clinical Trials in EU
Iris Loew-Friedrich, DrMed
UCB SA, Belgium
Executive Vice President and Chief Medical Officer
Kazuhiko Mori, PhD, MSc
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Senior Managing Director
¿Tiene una cuenta?